News archive
In vitro: Investigation of the cholesterol influence between tumor and its immune cells
Wednesday, 01 December 2021 10:34Using a self-developed in vitro model, scientists at Saarland University were able to show that the lipid and cholesterol metabolism of tumor-associated immune cells is severely impaired in contrast to that of tumor tissue.
Rare diseases: Myasthenia gravis studied using Organ-on-a-chip Technology
Monday, 29 November 2021 10:53Researchers at the University of Central Florida and at Hesperos, a company based in Orlando, have developed an organ-on-a-chip model to study the mechanisms of the rare autoimmune disease myasthenia gravis.
Cologne: Herbert Stiller Prize II for in silico researcher
Sunday, 28 November 2021 19:37Dr. Wolfgang Boomgaarden, founder and owner of the Emden-based company PharmaInformatic, has been awarded the Herbert Stiller Prize by the association Doctors Against Animal Experiments.
Cologne: Herbert Stiller Prize for 3D oral mucosa model
Tuesday, 09 November 2021 13:34This year, the Herbert Stiller Prize of the association Doctors Against Animal Experiments goes to Dr. Klara Janjić and her team from the Medical Faculty of the University of Vienna. The researchers have developed a 3D model of the human oral mucosa, which is used to study periodontal disease. However, the model could also help to end animal experiments in dentistry.
Stress research with cerebral organoids
Friday, 29 October 2021 11:21Scientists at the Max Planck Institute of Psychiatry led by Prof. Dr. Elisabeth Binder have shown that cerebral organoids are a suitable model system to study how stress affects human brain development.
Covid-19: Early messenger activation prevents viral combat
Thursday, 28 October 2021 12:45Using cells from patients, researchers at Charité - Universitätsmedizin Berlin, together with scientists from the German Rheumatism Research Center Berlin (DRFZ), have identified an important component in the progression of severe Covid-19 cases. They were able to demonstrate that NK cells, which normally contribute to the early control of SARS-CoV-2, are hindered by the early release of TGFβ.
Online workshop for young scientists
Thursday, 28 October 2021 09:22The Center for Alternatives to Animal Testing (CAAT) at Johns Hopkins University together with the Animal Welfare Officer of the State of Berlin invite young scientists to a two-day online workshop on November 22-23. The topic is non-animal New Approach Methodologies (NAMs) in biomedical research.
Munich: Tumor organoids to combat therapy resistance
Thursday, 28 October 2021 09:02Using tumor organoids from patients, scientists from the German Consortium for Translational Cancer Research (DKTK) at LMU Munich have been able to show that they can specifically adapt therapy to the individual disease thereby possibly preventing resistance.
Provivo Biosciences (formerly LPT): animal testing as responsible and animal welfare-oriented as possible
Wednesday, 20 October 2021 19:22Provivo Biosciences (formerly LPT), a service provider, plans to minimize animal testing at all of its sites by January of next year and work predominantly in vitro.
New Einstein Center 3R (EC3R) to build trust in 3R research among the scientific community and the public
Friday, 15 October 2021 17:05On July 1, the Einstein Center 3R was launched in Berlin. Its goal is to contribute to reduce or replace animal testing in certain areas of biomedical research with in vitro methods. It will initially be funded with around 5.3 million euros from the Einstein Foundation until the end of 2026. We spoke with the EC3R's head of communications and public relations, Prof. Dr. Jens Kurreck, about the center's tasks and goals.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.